Medicine supply notification: Amiodarone 100mg and 200mg tablets
Amiodarone 100mg and 200mg tablets are in limited supply until the week commencing 17 November 2025. Amiodarone suspension remains available (specials), and unlicensed imports of amiodarone of 100mg and 200mg tablets have been sourced (lead times vary).
Source: Community Pharmacy England
Medicine supply notification: Antimicrobial agents used in tuberculosis (TB) treatment
Following the national patient safety alert issued on 29 July 2025, the supply situation for antimicrobial medicines used to treat tuberculosis has significantly improved, and updated information in this medicines supply notification supersedes the alert.
Source: Community Pharmacy England
Mometasone (Asmanex Twisthaler®) dry powder inhalers are being discontinued (200 microgram per dose, 60 dose from Oct 2025; 200 microgram per dose 60 dose and 400 microgram per dose 30 and 60 dose from Feb 2026). Alternative corticosteroid inhalers are can bridge supply gap.
Source: Community Pharmacy England
SSPs for cefalexin oral suspensions sugar free further extended
SSPs for cefalexin 125mg/5ml oral suspension sugar free (SSP077) and cefalexin 250mg/5ml oral suspension sugar free (SSP078) were due to expire on 24 October 2025 but they have now been further extended to Friday 28 November 2025.
Source: Community Pharmacy England